About Quantified Imaging

Quantified Imaging develops non-invasive MRI diagnostic tools utilizing Arterial Spin Labeling (ASL) and Chemical Exchange Saturation Transfer (CEST) technologies to enhance the understanding of neurodegeneration and oncology. Their solutions aim to improve diagnostic accuracy and reduce scan times, thereby accelerating clinical trials and research workflows.

```xml <problem> Conventional MRI techniques for assessing neurodegeneration and oncology often require contrast agents or tracers, which can be invasive or carry risks for certain patient populations. Traditional methods may also suffer from limitations in sensitivity and specificity, hindering early and accurate diagnosis. </problem> <solution> Quantified Imaging develops non-invasive MRI diagnostic tools based on Arterial Spin Labeling (ASL) and Chemical Exchange Saturation Transfer (CEST) technologies. These techniques enable the measurement of perfusion and molecular changes in the brain without the need for contrast agents or radioactive exposure. By applying variational Bayesian inference machine learning technology, the company's solutions aim to improve diagnostic accuracy, reduce scan times, and simplify clinical workflows. The technology facilitates a better understanding of disease progression and accelerates clinical trials in neurodegeneration and oncology. </solution> <features> - Non-invasive perfusion measurement using Arterial Spin Labeling (ASL) MRI. - Tracer-free molecular imaging with Chemical Exchange Saturation Transfer (CEST) MRI. - Gold-standard variational Bayesian inference machine learning for image analysis. - Streamlined clinical workflows for improved efficiency. - Enhanced diagnostic accuracy for early detection of neurodegeneration and oncology. - Applications in dementia and traumatic brain injury diagnosis. </features> <target_audience> The primary target audience includes clinical radiologists, neurologists, oncologists, and researchers focused on neurodegeneration and oncology, as well as pharmaceutical companies conducting clinical trials. </target_audience> ```

What does Quantified Imaging do?

Where is Quantified Imaging located?

Quantified Imaging is based in London, United Kingdom.

When was Quantified Imaging founded?

Quantified Imaging was founded in 2023.

Who founded Quantified Imaging?

Quantified Imaging was founded by Tom Kirk.

Tom Kirk - Co-founder/CEO

Location

London, United Kingdom

Founded

2023

Employees

7 employees

Investors

Nottinghamtech Ventures

Quantified Imaging

London, United KingdomFounded 20237300+ followers9/10 TractionRelative Traction Score based on online presence metrics compared to companies in the same age group.

Updated 20 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Conventional MRI techniques for assessing neurodegeneration and oncology often require contrast agents or tracers, which can be invasive or carry risks for certain patient populations. Traditional methods may also suffer from limitations in sensitivity and specificity, hindering early and accurate diagnosis.

Solution

Quantified Imaging develops non-invasive MRI diagnostic tools based on Arterial Spin Labeling (ASL) and Chemical Exchange Saturation Transfer (CEST) technologies. These techniques enable the measurement of perfusion and molecular changes in the brain without the need for contrast agents or radioactive exposure. By applying variational Bayesian inference machine learning technology, the company's solutions aim to improve diagnostic accuracy, reduce scan times, and simplify clinical workflows. The technology facilitates a better understanding of disease progression and accelerates clinical trials in neurodegeneration and oncology.

Target Audience

The primary target audience includes clinical radiologists, neurologists, oncologists, and researchers focused on neurodegeneration and oncology, as well as pharmaceutical companies conducting clinical trials.

Features

Non-invasive perfusion measurement using Arterial Spin Labeling (ASL) MRI.
Tracer-free molecular imaging with Chemical Exchange Saturation Transfer (CEST) MRI.
Gold-standard variational Bayesian inference machine learning for image analysis.
Streamlined clinical workflows for improved efficiency.
Enhanced diagnostic accuracy for early detection of neurodegeneration and oncology.
Applications in dementia and traumatic brain injury diagnosis.